MESA LABORATORIES INC CO

For the period ended Dec 31, 2023. Filed Feb 5, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 5, 2024

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income

(in thousands, except per share data)

	Three Months Ended December 31,		Nine Months Ended December 31,
	2023	2022	2023	2022
Revenues	$53,473	$54,287	$157,283	$163,489
Cost of revenues	20,071	21,522	60,589	62,997
Gross profit	33,402	32,765	96,694	100,492
Operating expense:
Selling	9,737	8,437	28,363	27,660
General and administrative	19,438	16,129	55,024	54,543
Research and development	4,294	4,797	14,098	15,486
Total operating expense	33,469	29,363	97,485	97,689
Operating (loss) income	(67)	3,402	(791)	2,803
Nonoperating expense:
Interest expense and amortization of debt issuance costs	1,856	1,162	3,809	3,390
Other (income) expense, net	(3,869)	324	(4,284)	(475)
Total nonoperating (income) expense, net	(2,013)	1,486	(475)	2,915
Earnings (loss) before income taxes	1,946	1,916	(316)	(112)
Income tax (benefit) expense	(170)	1,465	(653)	(431)
Net income	$2,116	$451	$337	$319
Earnings per share:
Basic	$0.39	$0.08	$0.06	$0.06
Diluted	$0.39	$0.08	$0.06	$0.06
Weighted-average common shares outstanding:
Basic	5,393	5,339	5,384	5,312
Diluted	5,396	5,360	5,394	5,354

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.